AI-Driven Sales Transformation: Second Nature raises $22M to Leap Toward Future-Ready Customer Engagement

In the evolving landscape of sales and customer service, where artificial intelligence increasingly reshapes human interactions, one startup is gaining decisive momentum. Second Nature, a dynamic AI-powered training platform, has secured $22 million in a Series B funding round, signaling strong investor confidence in its vision to revolutionize how sales and service teams prepare for…

Read More

Attivare Therapeutics Secures $6.6 Million Grant to Advance Long-Lasting Malaria Vaccine Innovation

Attivare Therapeutics, Inc. has been awarded a $6.6 million grant from the Gates Foundation to accelerate development of a next-generation malaria vaccine designed for durability, affordability, and global accessibility. The funding supports advancement of the company’s proprietary ATTimmune™ bioscaffold platform, with a focus on populations in low- and middle-income countries where cold-chain logistics and repeat…

Read More

Aeovian Pharmaceuticals Secures $55 Million to Revolutionize Treatment for Refractory Tuberous Sclerosis Complex Epilepsy

Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company focused on restoring cellular metabolic quality control, has successfully closed an oversubscribed $55 million Series B financing. This substantial investment is earmarked to propel the development of its lead candidate, AV078, a first-in-class, CNS-penetrant selective mTORC1 inhibitor, and finance the completion of its crucial Phase 2 proof-of-concept study. The…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More

Alpine Space Ventures Injects €170 Million to Propel European Space Tech Innovation

The European space industry has received a momentous boost with the announcement of a substantial €170 million investment fund by Alpine Space Ventures. This venture capital firm, led by industry veterans Bulent Altan and Joram Voelklein, aims to catalyze the next wave of innovation in space technology across Europe. Alpine Space Ventures’ strategic focus is…

Read More
Dr. Beau Wangtrakuldee, a Ph.D, Amorsui

AmorSui Secures $3.5M Seed Funding to Transform Sustainable Medical Supplies

AmorSui, an innovative leader in sustainable personal protective equipment (PPE), has announced the completion of a $3.5 million seed funding round. This strategic investment, led by Gold House Ventures, The MBA Fund, and The Rev Up Fund, will fuel the company’s mission to enhance the safety and environmental responsibility of medical supplies. AmorSui aims to…

Read More

Sweden’s Liquid Wind Secures €3.6 Million Boost to Pioneer Large-Scale Green eMethanol Production

In a decisive stride toward sustainable fuel innovation, Liquid Wind, a trailblazer in renewable energy, has garnered €3.6 million from Industriklivet, a Swedish Energy Agency program dedicated to accelerating the country’s industrial green transition. This critical funding supports the pre-engineering phase of Liquid Wind’s ambitious full-scale eMethanol plant in Örnsköldsvik, Sweden—an initiative poised to transform…

Read More

QpiAI Secures $6.5 Million Pre-Series A Funding to Propel Quantum Computing and Generative AI Innovations

QpiAI, a leading enterprise in the realm of quantum computing and generative AI, has successfully closed its first external financing round amounting to $6.5 million. This investment, led by Yournest and SIDBI Venture Capital, marks a significant milestone for the company as it accelerates the development of cutting-edge products and platforms in quantum computing and…

Read More

Boostly Secures $5.6 Million Seed Funding to Transform Restaurant Marketing

In a significant move poised to revolutionize restaurant marketing, Boostly has announced the successful completion of a $5.6 million seed funding round. This investment was spearheaded by Trestle Partners and includes contributions from Relish Works, Singularity Capital, and Y Combinator. The funds are set to propel Boostly’s mission of equipping restaurants with cutting-edge tools to…

Read More